SCHEMBL14060082

SCHEMBL14060082

Clc1cccc(Cl)c1-c1nc(-c2ccsc2)[nH]c1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 13/20 0.49
MAPK12 P53778 13/20 0.49
MAPK11 Q15759 13/20 0.49
MAPK14 Q16539 13/20 0.49
RAF1 P04049 10/20 0.49
MAPK9 P45984 1/20 0.47
GCGR P47871 3/20 0.46
BRAF P15056 3/20 0.45
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
PPARG P37231 1/20 0.44
KMT2A Q03164 1/20 0.44
NCOA2 Q15596 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14060614 0.87 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL31305575 0.87 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060204 0.86 MAPK13 (0.49) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL31305443 0.86 MAPK13 (0.49) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060157 0.84 MAPK13 (0.64) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060694 0.84 MAPK13 (0.70) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060675 0.83 MAPK13 (0.70) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060485 0.83 MAPK13 (0.69) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL28397209 0.82 MAPK13 (0.71) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060772 0.82 MAPK13 (0.71) MAPK13MAPK12MAPK11MAPK14RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250215572-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY SHIKOKU CHEMICALS CORPORATION (JP) 2025-07-03 US disclosed
EP-4506488-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY Shikoku Chemicals Corporation (JP) 2025-02-12 EP disclosed
CN-118922584-A Surface treating agent for copper or copper alloy 四国化成工业株式会社 2024-11-08 CN disclosed
WO-2023190263-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY 四国化成工業株式会社 2023-10-05 WO disclosed
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2019-08-27 US disclosed
US-20170064823-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2017-03-02 US disclosed
US-9532493-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2016-12-27 US disclosed
EP-2714962-B1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEM (JP) 2015-07-08 EP disclosed
US-20140097231-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2014-04-10 US disclosed
CN-103547706-A Surface treatment composition for copper and copper alloy and use thereof SHIKOKU CHEM 2014-01-29 CN disclosed
WO-2012161341-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2012-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SOD1, SOD3, AOC3 MAPK13 1347/4885MAPK12 1599/4885MAPK11 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.